Notícias Eulerpool Psyence Group

Psyence Group Eulerpool-AFX

Psyence Group Notícias de ações

Psyence Group é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Psyence Group nós reunimos aqui.

• 18 de setembro ·

  Yahoo
  Psyence Group's NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
• 16 de setembro ·

  Yahoo
  Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
• 26 de julho ·

  Yahoo
  Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial
• 16 de abril ·

  Yahoo
  Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
• 26 de março ·

  Yahoo
  Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
• 12 de março ·

  Yahoo
  Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
• 11 de março ·

  Yahoo
  Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division
• 26 de janeiro ·

  Yahoo
  Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp
• 16 de janeiro ·

  Yahoo
  Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination
• 20 de novembro ·

  Yahoo
  Psyence Group Announces Resignation of Board Member